JP2004526747A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004526747A5 JP2004526747A5 JP2002578972A JP2002578972A JP2004526747A5 JP 2004526747 A5 JP2004526747 A5 JP 2004526747A5 JP 2002578972 A JP2002578972 A JP 2002578972A JP 2002578972 A JP2002578972 A JP 2002578972A JP 2004526747 A5 JP2004526747 A5 JP 2004526747A5
- Authority
- JP
- Japan
- Prior art keywords
- bone
- medicament
- bone graft
- bisphosphonate
- supplement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000988 bone and bone Anatomy 0.000 claims 41
- 239000003814 drug Substances 0.000 claims 38
- 229940122361 Bisphosphonate Drugs 0.000 claims 19
- 150000004663 bisphosphonates Chemical class 0.000 claims 19
- 239000013589 supplement Substances 0.000 claims 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 6
- 238000004519 manufacturing process Methods 0.000 claims 5
- 239000004568 cement Substances 0.000 claims 4
- 230000007547 defect Effects 0.000 claims 4
- 239000000499 gel Substances 0.000 claims 4
- 239000007788 liquid Substances 0.000 claims 4
- 230000004819 osteoinduction Effects 0.000 claims 4
- 210000001185 bone marrow Anatomy 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 238000001356 surgical procedure Methods 0.000 claims 3
- XRASPMIURGNCCH-UHFFFAOYSA-N zoledronic acid Chemical group OP(=O)(O)C(P(O)(O)=O)(O)CN1C=CN=C1 XRASPMIURGNCCH-UHFFFAOYSA-N 0.000 claims 3
- 108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 claims 2
- 102100022544 Bone morphogenetic protein 7 Human genes 0.000 claims 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 2
- 102000008186 Collagen Human genes 0.000 claims 2
- 108010035532 Collagen Proteins 0.000 claims 2
- 206010017076 Fracture Diseases 0.000 claims 2
- 108010010803 Gelatin Proteins 0.000 claims 2
- 229920000954 Polyglycolide Polymers 0.000 claims 2
- 230000037396 body weight Effects 0.000 claims 2
- 229910052791 calcium Inorganic materials 0.000 claims 2
- 239000011575 calcium Substances 0.000 claims 2
- 229920001436 collagen Polymers 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- 230000004927 fusion Effects 0.000 claims 2
- 229920000159 gelatin Polymers 0.000 claims 2
- 239000008273 gelatin Substances 0.000 claims 2
- 235000019322 gelatine Nutrition 0.000 claims 2
- 235000011852 gelatine desserts Nutrition 0.000 claims 2
- 230000006698 induction Effects 0.000 claims 2
- 208000014674 injury Diseases 0.000 claims 2
- 229920000747 poly(lactic acid) Polymers 0.000 claims 2
- 239000004633 polyglycolic acid Substances 0.000 claims 2
- 239000004626 polylactic acid Substances 0.000 claims 2
- 229920005989 resin Polymers 0.000 claims 2
- 239000011347 resin Substances 0.000 claims 2
- 230000008733 trauma Effects 0.000 claims 2
- OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 claims 1
- 208000010392 Bone Fractures Diseases 0.000 claims 1
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 claims 1
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 claims 1
- 206010061573 Congenital pseudarthrosis Diseases 0.000 claims 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 claims 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- MPBVHIBUJCELCL-UHFFFAOYSA-N Ibandronate Chemical compound CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O MPBVHIBUJCELCL-UHFFFAOYSA-N 0.000 claims 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000002565 Open Fractures Diseases 0.000 claims 1
- 108090000573 Osteocalcin Proteins 0.000 claims 1
- 102000004067 Osteocalcin Human genes 0.000 claims 1
- 208000003076 Osteolysis Diseases 0.000 claims 1
- 206010031252 Osteomyelitis Diseases 0.000 claims 1
- 208000001647 Renal Insufficiency Diseases 0.000 claims 1
- IIDJRNMFWXDHID-UHFFFAOYSA-N Risedronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CC1=CC=CN=C1 IIDJRNMFWXDHID-UHFFFAOYSA-N 0.000 claims 1
- 102000013275 Somatomedins Human genes 0.000 claims 1
- DKJJVAGXPKPDRL-UHFFFAOYSA-N Tiludronic acid Chemical compound OP(O)(=O)C(P(O)(O)=O)SC1=CC=C(Cl)C=C1 DKJJVAGXPKPDRL-UHFFFAOYSA-N 0.000 claims 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 1
- UGEPSJNLORCRBO-UHFFFAOYSA-N [3-(dimethylamino)-1-hydroxy-1-phosphonopropyl]phosphonic acid Chemical compound CN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O UGEPSJNLORCRBO-UHFFFAOYSA-N 0.000 claims 1
- 230000002745 absorbent Effects 0.000 claims 1
- 239000002250 absorbent Substances 0.000 claims 1
- 229940062527 alendronate Drugs 0.000 claims 1
- 230000000735 allogeneic effect Effects 0.000 claims 1
- 229910045601 alloy Inorganic materials 0.000 claims 1
- 239000000956 alloy Substances 0.000 claims 1
- 208000037873 arthrodesis Diseases 0.000 claims 1
- 238000011882 arthroplasty Methods 0.000 claims 1
- 229920000249 biocompatible polymer Polymers 0.000 claims 1
- 229960002286 clodronic acid Drugs 0.000 claims 1
- ACSIXWWBWUQEHA-UHFFFAOYSA-N clodronic acid Chemical compound OP(O)(=O)C(Cl)(Cl)P(O)(O)=O ACSIXWWBWUQEHA-UHFFFAOYSA-N 0.000 claims 1
- 230000037416 cystogenesis Effects 0.000 claims 1
- 230000003111 delayed effect Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- IWLDTXOHXPDPQG-UHFFFAOYSA-L disodium;hydroxy-[1-hydroxy-1-[hydroxy(oxido)phosphoryl]-3-pyrrolidin-1-ylpropyl]phosphinate Chemical compound [Na+].[Na+].OP(=O)(O)C(P([O-])([O-])=O)(O)CCN1CCCC1 IWLDTXOHXPDPQG-UHFFFAOYSA-L 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 229940009626 etidronate Drugs 0.000 claims 1
- 229940126864 fibroblast growth factor Drugs 0.000 claims 1
- 210000002082 fibula Anatomy 0.000 claims 1
- 229940015872 ibandronate Drugs 0.000 claims 1
- LWRDQHOZTAOILO-UHFFFAOYSA-N incadronic acid Chemical compound OP(O)(=O)C(P(O)(O)=O)NC1CCCCCC1 LWRDQHOZTAOILO-UHFFFAOYSA-N 0.000 claims 1
- 229950006971 incadronic acid Drugs 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 201000006370 kidney failure Diseases 0.000 claims 1
- 208000029791 lytic metastatic bone lesion Diseases 0.000 claims 1
- 210000004373 mandible Anatomy 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 210000002050 maxilla Anatomy 0.000 claims 1
- 208000030159 metabolic disease Diseases 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 150000002739 metals Chemical class 0.000 claims 1
- VMMKGHQPQIEGSQ-UHFFFAOYSA-N minodronic acid Chemical compound C1=CC=CN2C(CC(O)(P(O)(O)=O)P(O)(O)=O)=CN=C21 VMMKGHQPQIEGSQ-UHFFFAOYSA-N 0.000 claims 1
- 229950011129 minodronic acid Drugs 0.000 claims 1
- PUUSSSIBPPTKTP-UHFFFAOYSA-N neridronic acid Chemical compound NCCCCCC(O)(P(O)(O)=O)P(O)(O)=O PUUSSSIBPPTKTP-UHFFFAOYSA-N 0.000 claims 1
- 229950010733 neridronic acid Drugs 0.000 claims 1
- 230000002138 osteoinductive effect Effects 0.000 claims 1
- WRUUGTRCQOWXEG-UHFFFAOYSA-N pamidronate Chemical group NCCC(O)(P(O)(O)=O)P(O)(O)=O WRUUGTRCQOWXEG-UHFFFAOYSA-N 0.000 claims 1
- 229940046231 pamidronate Drugs 0.000 claims 1
- 230000000849 parathyroid Effects 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 229940089617 risedronate Drugs 0.000 claims 1
- 210000003625 skull Anatomy 0.000 claims 1
- 210000000278 spinal cord Anatomy 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 1
- 210000002303 tibia Anatomy 0.000 claims 1
- 229940019375 tiludronate Drugs 0.000 claims 1
- 239000010936 titanium Substances 0.000 claims 1
- 229910052719 titanium Inorganic materials 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- 230000005740 tumor formation Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPR4187A AUPR418701A0 (en) | 2001-04-03 | 2001-04-03 | A drug for use in bone grafting |
| AUPR9613A AUPR961301A0 (en) | 2001-12-17 | 2001-12-17 | A drug for use in bone grafting |
| PCT/AU2002/000412 WO2002080933A1 (en) | 2001-04-03 | 2002-03-28 | A drug for use in bone grafting |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004526747A JP2004526747A (ja) | 2004-09-02 |
| JP2004526747A5 true JP2004526747A5 (https=) | 2005-12-22 |
Family
ID=25646639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002578972A Pending JP2004526747A (ja) | 2001-04-03 | 2002-03-28 | 骨移植で使用される医薬 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040157798A1 (https=) |
| EP (1) | EP1383509A4 (https=) |
| JP (1) | JP2004526747A (https=) |
| AU (1) | AU2002244520B2 (https=) |
| NZ (1) | NZ528659A (https=) |
| WO (1) | WO2002080933A1 (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0300620D0 (sv) * | 2003-03-05 | 2003-03-05 | Bone Support Ab | A new bone substitute composition |
| WO2005027921A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bisphosphonate |
| SE0302983D0 (sv) | 2003-11-11 | 2003-11-11 | Bone Support Ab | Anordning för att förse spongiöst ben med benersättnings- och/eller benförstärkningsmaterial och förfarande i samband därmed |
| ITMI20040218A1 (it) * | 2004-02-10 | 2004-05-10 | Abiogen Pharma Spa | Uso di neridronato sodico per promuovere la neoformazione ossea |
| SE527528C2 (sv) | 2004-06-22 | 2006-04-04 | Bone Support Ab | Anordning för framställning av härdbar massa samt användning av anordningen |
| US8852240B2 (en) | 2004-10-25 | 2014-10-07 | Kieran Murphy, Llc | Methods and compositions for fostering and preserving bone growth |
| US8071574B2 (en) * | 2005-02-22 | 2011-12-06 | John Dennis Bobyn | Implant improving local bone formation |
| US20070077267A1 (en) * | 2005-10-03 | 2007-04-05 | Sdgi Holdings, Inc. | Bioactive composite implants |
| US8287596B1 (en) * | 2006-10-11 | 2012-10-16 | Nuvasive, Inc. | Intraoperative surgical barrier and related methods |
| WO2008073628A2 (en) * | 2006-11-03 | 2008-06-19 | Biomimetic Therapeutics, Inc. | Compositions and methods for arthrodetic procedures |
| TW200848064A (en) * | 2007-03-06 | 2008-12-16 | Takara Bio Inc | Process for producing osteocalcin-containing extract |
| WO2008133618A1 (en) * | 2007-04-27 | 2008-11-06 | Unigene Laboratories, Inc. | Methods and compositions for fostering and preserving bone growth |
| US20160016982A1 (en) | 2009-07-31 | 2016-01-21 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
| US9169279B2 (en) | 2009-07-31 | 2015-10-27 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
| CA2769633C (en) * | 2009-07-31 | 2017-06-06 | Thar Pharma, Llc | Crystallization method and bioavailability |
| US8882740B2 (en) * | 2009-12-23 | 2014-11-11 | Stryker Trauma Gmbh | Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone |
| US9180137B2 (en) | 2010-02-09 | 2015-11-10 | Bone Support Ab | Preparation of bone cement compositions |
| US20110307074A1 (en) * | 2010-05-24 | 2011-12-15 | University Of The Witwatersrand, Johannesburg | Biomaterials for use in methods of bone replacement therapy |
| WO2012071517A2 (en) | 2010-11-24 | 2012-05-31 | Thar Pharmaceuticals, Inc. | Novel crystalline forms |
| EP2688498A1 (en) * | 2011-03-21 | 2014-01-29 | Ronald Childs | Sleeve for bone fixation device |
| GB201200868D0 (en) * | 2012-01-19 | 2012-02-29 | Depuy Int Ltd | Bone filler composition |
| US20140234435A1 (en) | 2013-02-20 | 2014-08-21 | Bone Support Ab | Setting of hardenable bone substitute |
| US10238507B2 (en) | 2015-01-12 | 2019-03-26 | Surgentec, Llc | Bone graft delivery system and method for using same |
| CN107660153A (zh) * | 2015-03-23 | 2018-02-02 | 骨支撑股份公司 | 双相陶瓷骨替代物 |
| US20180289859A1 (en) * | 2015-10-05 | 2018-10-11 | Hettwer Holding Aps | Compositions and methods for treatment of bone defects |
| WO2017208070A1 (en) | 2016-05-31 | 2017-12-07 | Grünenthal GmbH | Bisphosphonic acid and coformers with lysin, glycin, nicotinamide for treating psoriatic arthritis |
| US10687828B2 (en) | 2018-04-13 | 2020-06-23 | Surgentec, Llc | Bone graft delivery system and method for using same |
| US11116647B2 (en) | 2018-04-13 | 2021-09-14 | Surgentec, Llc | Bone graft delivery system and method for using same |
| WO2019206677A1 (en) * | 2018-04-23 | 2019-10-31 | Seagles Ab | Novel treatment approach by targeted delivery of bioactive molecules bio modulated ceramics |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5208219A (en) * | 1991-02-14 | 1993-05-04 | Celtrix Pharmaceuticals Inc. | Method for inducing bone growth |
| EP0523926A3 (en) * | 1991-07-15 | 1993-12-01 | Smith & Nephew Richards Inc | Prosthetic implants with bioabsorbable coating |
| EP0675723A4 (en) * | 1992-12-23 | 1998-08-05 | Merck & Co Inc | THERAPY USING BISPHOSPHONATES AND STROGENS TO TREAT AND PREVENT BONE RESORPTION. |
| US5403829A (en) * | 1993-03-24 | 1995-04-04 | Leiras Oy | Use of bisphosphonates in endo-osteal bone surgery |
| US5646134A (en) * | 1994-04-21 | 1997-07-08 | Merck & Co., Inc. | Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices |
| WO1996039107A1 (en) * | 1995-06-06 | 1996-12-12 | Merck & Co., Inc. | Bisphosphonate cement composition to prevent aseptic loosening of orthopedic implant devices |
| EP0950417A3 (en) * | 1998-02-23 | 2000-02-23 | Pfizer Products Inc. | Treatment of skeletal disorders |
| WO2000047214A1 (en) * | 1999-02-09 | 2000-08-17 | Sloan-Kettering Institute For Cancer Research | Anti-resorptive bone cements and allogeneic, autografic, and xenografic bone grafts |
| AUPQ232599A0 (en) * | 1999-08-19 | 1999-09-09 | Royal Alexandra Hospital For Children, The | Drug for treating fractures |
| CA2410201C (en) * | 2000-06-20 | 2010-10-26 | Novartis Ag | Zoledronic acid or salts thereof for use in the treatment of conditions of abnormally increased bone turnover |
| EP1365769B1 (en) * | 2001-02-06 | 2011-01-26 | The Sydney Children's Hospitals Network (Randwick and Westmead) (incorporating The Royal Alexandra Hospital for Children) | A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis |
-
2002
- 2002-03-28 NZ NZ528659A patent/NZ528659A/en unknown
- 2002-03-28 US US10/474,072 patent/US20040157798A1/en not_active Abandoned
- 2002-03-28 EP EP02712634A patent/EP1383509A4/en not_active Withdrawn
- 2002-03-28 JP JP2002578972A patent/JP2004526747A/ja active Pending
- 2002-03-28 WO PCT/AU2002/000412 patent/WO2002080933A1/en not_active Ceased
- 2002-03-28 AU AU2002244520A patent/AU2002244520B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004526747A5 (https=) | ||
| AU2002244520B2 (en) | A drug for use in bone grafting | |
| Jiménez et al. | Bibliographic review on the state of the art of strontium and zinc based regenerative therapies. Recent developments and clinical applications | |
| Agrawal et al. | A review on carrier systems for bone morphogenetic protein‐2 | |
| AU2002244520A1 (en) | A drug for use in bone grafting | |
| US6077916A (en) | Biodegradable mixtures of polyphoshazene and other polymers | |
| EP2678050B1 (en) | Noggin blocking compositions for ossification and methods related thereto | |
| CN109010916B (zh) | 在脱细胞组织基质中含有氧固醇的可模塑制剂 | |
| JP2004527479A5 (https=) | ||
| Qi et al. | Advances in magnesium-containing bioceramics for bone repair | |
| HUP0303013A2 (hu) | Gyógyszer csontelhalás kezelésére és olyan betegek gondozására, akiknél a csontelhalás kialakulásának kockázata áll fenn | |
| Vertenten et al. | Enhancing bone healing and regeneration: present and future perspectives in veterinary orthopaedics | |
| WO2018209101A1 (en) | Medical and dental integrated multiphasic biomaterials for single or multi-tissue reconstruction/regeneration | |
| JP7837939B2 (ja) | 人工骨膜 | |
| Vignolo et al. | Strategies for craniofacial tissue engineering: Innovations for scalable bone regeneration | |
| US20220023493A1 (en) | Compositions and methods for regeneration of bone tissue | |
| CN1416913A (zh) | 自固化磷酸钙原位成骨活性骨水泥及其制备方法和应用 | |
| Alsolaihim et al. | Biomimetic regenerative materials in restorative dentistry and endodontics | |
| Choi et al. | Mineral nanoparticles and nanocomposite hydrogels with osteoinductive properties for bone regeneration | |
| TWI913607B (zh) | 多孔鈣基顆粒用於促進一骨折骨的關節內或關節周圍骨折的癒合的用途 | |
| US20260108431A1 (en) | Bioactive composites for bone void filler compositions and methods | |
| KR102215165B1 (ko) | 일산화질소 복합체를 포함하는 골형성 촉진용 조성물 | |
| Yu et al. | Research Advances in the Principle of Autologous Guided Bone Regeneration in Craniomaxillofacial Surgery | |
| He et al. | Regenerative Approaches in Orthodontic and Orthopedic Treatment | |
| Lagares | Nanobiomaterials in hard tissue engineering |